|
High-level Kenyan delegation to discuss investments, regulatory landscape with Indian pharma industry
|
|
Shardul Nautiyal, Mumbai
December 02 , 2025
|
|
|
High-level Kenyan delegation led by Lee Kinyanjui, cabinet secretary for Investments, Trade and Industry, Government of Kenya, along with senior officials from Regulatory Affairs, will be visiting India to discuss investments and regulatory landscape with Indian pharma industry on December 03, 2025.
The Kenyan Delegation’s visit is an important development as regional demand for locally manufactured medicines continues to grow as African governments work to reduce import dependency.
Kenya serves as the gateway to East and Central Africa, offering access to a combined market of over 400 million consumers through the East African Community (EAC), the Common Market for Eastern and Southern Africa (COMESA), and the African Continental Free Trade Area (AfCFTA). The country’s well-developed infrastructure, including modern road networks, airports, ports, and Special Economic Zones (SEZs) supports efficient manufacturing and export operations.
Officials from the ministry of investments, trade and industry and the ministry of foreign affairs, Government of Kenya, through the Kenya High Commission in New Delhi and the Kenya Investment Authority (Invest Kenya), in collaboration with the International Finance Corporation (IFC) will also hold key discussions with pharma industry and pharma exporters in New Delhi on December 03, 2025. This is aimed at Indian pharma industry enhanced participation towards strengthening India–Kenya collaboration in the pharmaceutical sector.
According to the Union commerce ministry, Africa accounted for 18% of India's USD 19.9 billion pharmaceutical exports in FY23. While some nations, including South Africa, Kenya, and Tanzania, recorded growth in imports, others like Nigeria, Ethiopia, and Uganda saw sharp declines.
To address currency volatility, the Reserve Bank of India (RBI) had in May, 2024 authorized 20 Indian banks to open 92 Special Rupee Vostro Accounts (SRVAs) with partner banks in 22 countries. These measures were aimed to facilitate trade in the Indian rupee and reduce dependence on the US dollar.
The fall in local currencies across Africa over the past one year has been making pharmaceutical imports more expensive, leading to reduced demand.
A significant decline in local currencies across Africa have been impacting countries like Nigeria, Ghana, Egypt, Zambia, and others against the US dollar, leading to rising import costs, increased debt burdens, and a decrease in purchasing power for citizens due to inflation.
Many African currencies also witnessed loss of a significant percentage of their value against the US dollar in the recent times, with some experiencing declines of over 30%.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|